ĢƵ

close

TAGGED : health

Grace Science Announces FDA Clearance of Investigational New Drug (IND) Application to Initiate a Phase 1/2/3 Trial for the Treatment of NGLY1 Deficiency with GS-100, an AAV9 NGLY1 Gene Therapy

MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Grace Science, LLC announced today that it has received FDA clearance of its Investigational New Drug (IND) application for GS-100, an AAV9 gene replacement therapy for the treatment of NGLY1 Deficiency.The clinical trial will utilize a ...

Sonendo to Participate at Upcoming November Investor Conferences

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave ® System, today announced that management will participate in three upcoming investor conferences in November.Sonendo management is scheduled to ...